1.1 Purpose The last decade has substantially broadened treatment options for patients with
thoracic aortic pathology involving the aortic arch. Traditionally, treatment of aortic arch …

Recently, sarcopenia has garnered renewed interest. Sarcopenia is a disease characterized
by decreased skeletal muscle mass and strength/function, which can impair the quality of life …

1.1. Purpose The last decade has substantially broadened treatment options for patients
with thoracic aortic pathology involving the aortic arch. Traditionally, treatment of aortic arch …

These guidelines, endorsed by both the EACTS and STS, represent the official viewpoint on
this topic. They show a commitment to ongoing improvement, as regular updates will be …

Background Frailty has no single universally accepted definition or method for assessment.
It is commonly defined from a physiological perspective as a disruption of homeostatic …

Objective Sarcopenia, age-related loss of muscle mass, is an objective and comprehensive
marker of frailty. We aimed to clarify the influence of sarcopenia on the outcomes after heart …

In an ageing population of patients with heart disease, preinterventional frailty assessment
for risk prediction is gaining relevance both in cardiac surgery and transcatheter valve …

With an unprecedented growth of the aging population anticipated in the next century,
understanding the health needs and demands of older adults is of crucial importance for the …

Background Quantification of abdominal muscle mass by cross-sectional imaging has been
increasingly used to diagnose sarcopenia; however, the technical method for quantification …

Objective Psoas muscle area (PMA) is a validated surrogate for muscle mass that can be
easily measured from a clinical CT scan. This study sought to determine whether PMA was …